Related Experiment Video
Updated: Aug 14, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Hepatocellular carcinoma outcomes based on indicated treatment strategy
A T Rose1, D M Rose, C W Pinson
1Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-4753, USA.
The American Surgeon
|December 8, 1998
Summary
Newer hepatocellular carcinoma (HCC) treatments show improved outcomes. Surgical options and liver transplantation offer superior survival rates for HCC patients compared to other therapies.
Area of Science:
- Hepatology
- Oncology
- Surgical Oncology
Background:
- Hepatocellular carcinoma (HCC) historically presents with poor survival rates in Western countries.
- Advancements in treatment strategies are crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the impact of contemporary treatment modalities on survival in patients with hepatocellular carcinoma (HCC).
- To compare the efficacy of surgical resection, chemoembolization, systemic therapy, and liver transplantation for HCC management.
Main Methods:
- A 7-year retrospective analysis of 117 patients diagnosed with HCC.
- Categorization of treatments included surgical resection, chemoembolization, systemic therapy, orthotopic liver transplantation, and supportive care.
- Survival rates were analyzed based on treatment group, cirrhosis status, and patient age.
Main Results:
- Orthotopic liver transplantation demonstrated the highest 1-, 2-, and 3-year survival rates (87%, 87%, 58%).
- Surgical resection also offered significant survival benefits compared to chemoembolization or systemic therapy alone.
- Patients without cirrhosis had a higher 1-year survival rate (47%) compared to those with cirrhosis (29%).
Conclusions:
- Surgical treatment strategies, particularly orthotopic liver transplantation and resection, are associated with superior survival in HCC patients.
- Early intervention and appropriate treatment selection are critical for improving outcomes in hepatocellular carcinoma.
- Further research into optimizing HCC treatment protocols is warranted.
